Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Patrick Y Wen & Jan Drappatz. (2006) Novel therapies for meningiomas. Expert Review of Neurotherapeutics 6:10, pages 1447-1464.
Read now
Read now
Michael W Graner & Darell D Bigner. (2006) Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology. Expert Review of Anticancer Therapy 6:5, pages 679-695.
Read now
Read now
Articles from other publishers (30)
Kannan Badri Narayanan, Rakesh Bhaskar & Sung Soo Han. (2022) Recent Advances in the Biomedical Applications of Functionalized Nanogels. Pharmaceutics 14:12, pages 2832.
Crossref
Crossref
Chao Hu, Kangni Chen & Xiaoping Tang. (2020) Prognostic value of preoperative controlling nutritional status in patients with glioblastoma. Clinical Neurology and Neurosurgery 198, pages 106129.
Crossref
Crossref
Malaka Ameratunga, Niamh Coleman, Liam Welsh, Frank Saran & Juanita Lopez. (2018) CNS cancer immunity cycle and strategies to target this for glioblastoma. Oncotarget 9:32, pages 22802-22816.
Crossref
Crossref
Tomas Garzon-Muvdi, Debebe Theodros, Andrew S. Luksik, Russell Maxwell, Eileen Kim, Christopher M. Jackson, Zineb Belcaid, Sudipto Ganguly, Betty Tyler, Henry Brem, Drew M. Pardoll & Michael Lim. (2018) Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma. Oncotarget 9:29, pages 20681-20697.
Crossref
Crossref
A Ellert-Miklaszewska, P Wisniewski, M Kijewska, P Gajdanowicz, D Pszczolkowska, P Przanowski, M Dabrowski, M Maleszewska & B Kaminska. (2016) Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression. Oncogene 35:50, pages 6366-6377.
Crossref
Crossref
Shuanglin Deng, Shan Zhu, Yuan Qiao, Yong-Jun Liu, Wei Chen, Gang Zhao & Jingtao Chen. (2014) Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma. Protein & Cell 5:12, pages 899-911.
Crossref
Crossref
Ching-Ting Tsao, Forrest M. Kievit, Ali Ravanpay, Ariane E. Erickson, Michael C. Jensen, Richard G. Ellenbogen & Miqin Zhang. (2014)
Thermoreversible Poly(ethylene glycol)-
g
-Chitosan Hydrogel as a Therapeutic T Lymphocyte Depot for Localized Glioblastoma Immunotherapy
. Biomacromolecules 15:7, pages 2656-2662.
Crossref
Crossref
S. Chandra, A.C. Pavlick & H.L. Kaufman. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Bozena Kaminska. 2014. Glioma Cell Biology. Glioma Cell Biology
241
270
.
Selby Chen & Ian F. Parney. 2014. Glioma Cell Biology. Glioma Cell Biology
221
239
.
Shinji Shimato, Lisa M. Anderson, Martin Asslaber, Jeffrey N. Bruce, Peter Canoll, David E. Anderson & Richard C. E. Anderson. (2013) Inhibition of Caveolin-1 Restores Myeloid Cell Function in Human Glioblastoma. PLoS ONE 8:10, pages e77397.
Crossref
Crossref
Aleksandra Ellert-Miklaszewska, Michal Dabrowski, Maciej Lipko, Marcin Sliwa, Marta Maleszewska & Bozena Kaminska. (2013) Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia 61:7, pages 1178-1190.
Crossref
Crossref
Sean E. Lawler & E. Antonio Chiocca. 2013. Genomic and Personalized Medicine. Genomic and Personalized Medicine
749
764
.
Seunggu J. Han, Corinna Zygourakis, Michael Lim & Andrew T. Parsa. (2012) Immunotherapy for Glioma. Neurosurgery Clinics of North America 23:3, pages 357-370.
Crossref
Crossref
Jacob Ruzevick, Christopher Jackson, Jillian Phallen & Michael Lim. (2012) Clinical Trials with Immunotherapy for High-Grade Glioma. Neurosurgery Clinics of North America 23:3, pages 459-470.
Crossref
Crossref
Manuel Nieto-SampedroBeatriz Valle-ArgosDiego Gómez-NicolaAlfonso Fernández-MayoralasManuel Nieto-Díaz. (2011) Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. Clinical Medicine Insights: Oncology 5, pages CMO.S7685.
Crossref
Crossref
Christopher Jackson, Jacob Ruzevick, Jillian Phallen, Zineb Belcaid & Michael Lim. (2011) Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment. Clinical and Developmental Immunology 2011, pages 1-20.
Crossref
Crossref
Serena Pellegatta, Pietro Luigi Poliani, Elena Stucchi, Daniela Corno, Chiara Agnese Colombo, Francesca Orzan, Maria Ravanini & Gaetano Finocchiaro. (2010) Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment. Neuro-Oncology 12:4, pages 377-388.
Crossref
Crossref
Emilia Albesiano, James E. Han & Michael Lim. (2010) Mechanisms of Local Immunoresistance in Glioma. Neurosurgery Clinics of North America 21:1, pages 17-29.
Crossref
Crossref
Seunggu J. Han, Gurvinder Kaur, Isaac Yang & Michael Lim. (2010) Biologic Principles of Immunotherapy for Malignant Gliomas. Neurosurgery Clinics of North America 21:1, pages 1-16.
Crossref
Crossref
Pierre Giglio. 2010. Glioblastoma. Glioblastoma
203
216
.
Benjamin C Kennedy, Lisa M Maier, Randy D'Amico, Christopher E Mandigo, Elizabeth J Fontana, Allen Waziri, Marcela C Assanah, Peter Canoll, Richard CE Anderson, David E Anderson & Jeffrey N Bruce. (2009) Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunology 10:1.
Crossref
Crossref
Sean E. Lawler & E. Antonio Chiocca. 2009. Genomic and Personalized Medicine. Genomic and Personalized Medicine
956
966
.
Thomas Calzascia, Jacelyn M. S. Loh, Wilma Di Berardino‐Besson, Frédérick Masson, Philippe Guillaume, Karim Burkhardt, Pedro L. Herrera, Pierre‐Yves Dietrich & Paul R. Walker. (2008) Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes. Glia 56:15, pages 1625-1636.
Crossref
Crossref
Athanasios Zisakis, Christina Piperi, Marios S. Themistocleous, Penelope Korkolopoulou, Efstathios I. Boviatsis, Damianos E. Sakas, Efstratios Patsouris, Robert W. Lea & Anastasios Kalofoutis. (2007) Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients. Cytokine 39:2, pages 99-105.
Crossref
Crossref
Regina S. Bower, Michael Lim & Griffith R. Harsh. (2007) Immunotherapy for Gliomas. Contemporary Neurosurgery 29:15, pages 1-6.
Crossref
Crossref
Regina S. Bower, Michael Lim & Griffith R. Harsh. (2007) Immunotherapy for Gliomas. Contemporary Neurosurgery 29:14, pages 1-6.
Crossref
Crossref
S.V. Suchkov, D.D. Petrunin, A.V. Kostalevskaya, I.A. Kachkov, T. Elbeik, E. Matsuura & M.A. Paltsev. (2007) Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation. Biomedicine & Pharmacotherapy 61:6, pages 323-337.
Crossref
Crossref
Susan Chang, Michael Vogelbaum, Frederick F. Lang, Stephen Haines, Sandeep Kunwar, E. Antonio Chiocca, Alessandro Olivi, Alfredo Quinones-Hinojosa, Andrew Parsa & Ronald Warnick. (2006) GNOSIS: Guidelines for Neuro-Oncology: Standards for Investigational Studies — reporting of surgically based therapeutic clinical trials. Journal of Neuro-Oncology 82:2, pages 211-220.
Crossref
Crossref
Margaret Wrensch, John K. Wiencke, Joe Wiemels, Rei Miike, Joe Patoka, Michelle Moghadassi, Alex McMillan, Karl T. Kelsey, Kenneth Aldape, Kathleen R. Lamborn, Andrew T. Parsa, Jennette D. Sison & Michael D. Prados. (2006) Serum IgE, Tumor Epidermal Growth Factor Receptor Expression, and Inherited Polymorphisms Associated with Glioma Survival. Cancer Research 66:8, pages 4531-4541.
Crossref
Crossref